Physician profile
Bashar G Yaldo
NPI 1407866536
$4,813.16
in general payments reported to CMS, 2019-2025
23 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,135 · 2020: $210 · 2021: $195 · 2022: $304 · 2023: $341 · 2024: $290 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $2,450.39 | 2019 | |
| Smith+Nephew, INC. | $1,318.97 | 2019-2025 | Grafix Pl, Renasys Touch, Renasys Go V2 Home |
| Kci USA, INC. | $196.57 | 2020-2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Kerecis Limited | $152.83 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Acera Surgical, INC. | $129.89 | 2025 | Restrata Wound Matrix |
| Organogenesis INC. | $115.27 | 2021-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Abbvie INC. | $74.50 | 2023 | |
| Integra Lifesciences Corporation | $56.62 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cashflow Solutions, LLC | $34.43 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Novo Nordisk INC | $26.86 | 2019 | |
| Urgo Medical North America, LLC | $24.77 | 2024 | Urgoclean Ag |
| Medela LLC | $24.69 | 2020 | |
| Tactile Systems Technology INC | $24.65 | 2025 | Flexitouch Plus, Nimbl |
| Medline Industries LP | $23.96 | 2024 | |
| Aroa Biosurgery Incorporated | $23.61 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23.55 | 2022 | |
| Mimedx Group, INC. | $22.86 | 2025 | |
| Solventum Corporation | $19.73 | 2024 | Activ.A.C. |
| Astellas Pharma US INC | $17.47 | 2019 | |
| Ethicon US, LLC | $16.31 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.31 | 2019 | |
| Bausch Health US, LLC | $11.74 | 2019 | |
| Heron Therapeutics, INC. | $8.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Yaldo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.